Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about pancreatic cancer
Recent news which mentions pancreatic cancer
Cancer 2023: What’s Happening in the Combat Zone?
July 18, 2023
Tags
Mirati Therapeutics (MRTX)
fluorouracil
Eli Lilly (LLY)
From
Stock Gumshoe
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
June 06, 2022
Tickers
BNTX
MRK
RHHBF
RHHBY
Tags
MRK
RHHVF
Phase 1 Trial
From
Benzinga
FDA Removes Clinical Hold On AIM ImmunoTech's Mid-Stage Ampligen Trial In Pancreatic Cancer
March 16, 2022
Tickers
AIM
Tags
News
FDA
Phase 2 Trial
From
Benzinga
AIM ImmunoTech Shares Encouraging Data From Ampligen Study In Pancreatic Cancer
March 09, 2022
Tickers
AIM
Tags
Market News
Health Care
Pancreatic Cancer
From
Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
February 15, 2022
Tickers
AMGN
Tags
Phase 2 Trial
News
AMGN
From
Benzinga
PharmaCyte Updates Status Of Investigational New Drug Application For Pancreatic Cancer Candidate
February 14, 2022
Tickers
PMCB
Tags
PMCB
Penny Stocks
Biotech
From
Benzinga
Immix Biopharma's IMX-110 / Anti-PD-1 Combo Therapy Shows Extended Median Survival In Animal Studies
January 25, 2022
Tickers
BGNE
IMMX
Tags
General
News
Market News
From
Benzinga
ImmunityBio's Shares Jump On Encouraging Data From Pancreatic Cancer Immunotherapy Trial
January 19, 2022
Tickers
IBRX
Tags
Market News
why it's moving
Pancreatic Cancer
From
Benzinga
Why Did HCW Biologics Shares More Than Double Today?
October 28, 2021
Tickers
HCWB
Tags
Market News
HCWB
Pancreatic Cancer
From
Benzinga
Gala to end Pancreatic Cancer Raises Over $1 Million
October 06, 2021
Tickers
AP
Tags
Kroger Atlanta
Medical Research
AP
From
Send2Press Newswire
Novocure To Test Its Tumor Treating Fields With Roche's Tecentriq In Pancreatic Cancer
September 14, 2021
Tickers
NVCR
RHHBF
RHHBY
RHHVF
Tags
News
Contracts
Pancreatic Cancer
From
Benzinga
See Why RenovoRx Stock Is Shooting Higher On Tuesday
September 07, 2021
Tickers
RNXT
Tags
General
FDA
Phase 3 Trial
From
Benzinga
Lantern Pharma Secures FDA Orphan Drug Tag For Pancreatic Cancer Candidate
August 11, 2021
Tickers
LTRN
Tags
Orphan Drug Designation
FDA
News
From
Benzinga
Why XOMA Stock Is Trading Higher Wednesday?
July 28, 2021
Tickers
AG
NVS
XOMA
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Novartis' TGFβ Targeted Antibody Secures FDA Orphan Drug Tag For Pancreatic Cancer
July 27, 2021
Tickers
NVS
Tags
Health Care
Briefs
Biotech
From
Benzinga
Lantern Pharma Shares Moves Higher On Encouraging Data From Pancreatic Cancer Candidate In Animal Models
July 20, 2021
Tickers
LTRN
Tags
Market News
Pancreatic Cancer
Health Care
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today